Items Tagged ‘Recurrent Pancreatic Cancer’

August 17th, 2016

Pancreatic Cancer Cells Find Unique Fuel Sources to Keep from Starving

By

Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source of nutrition. This is the finding of a study in cancer cells and mice published August 10 in Nature. The study was led by researchers from NYU Langone Medical Center, the Dana Farber Cancer Institute […]

View full entry

Tags: autophagy, fuel, HCQ, News, Pancreatic Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer, Stages I-III Pancreatic Cancer, stellate cells, study, tumors


November 26th, 2014

MM-398 Receives Fast Track Designation for Advanced Pancreatic Cancer

By

The U. S. Food and Drug Administration (FDA) has granted MM- 398 plus 5-fluorouracil (5-FU) and leucovorin a Fast Track designation as a second-line treatment for patients with metastatic pancreatic cancer, based on data from the phase III NAPOLI-1 study that were presented at the 2014 World Congress on Gastrointestinal Cancer in June 2014. MM-398 […]

View full entry

Tags: mm-398, News, Pancreatic Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer


October 7th, 2014

FDA Grants Orphan Drug Designation to Investigational Agent for Pancreatic Cancer

By

Pancreatic cancer is one of the deadliest forms of cancer. Each year, approximately 43,000 people are diagnosed with pancreatic cancer in the United States and close to 37,000 die from the disease. The disease is often diagnosed at an advanced stage, and treatment of advanced disease remains challenging. The current standard of care consists of […]

View full entry

Tags: News, Pancreatic Cancer, pegph2, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer


September 23rd, 2014

Simtuzumab Fails to Improve Outcomes in Pancreatic Cancer

By

Pancreatic cancer is one of the deadliest forms of cancer. Each year, approximately 43,000 people are diagnosed with pancreatic cancer in the United States and close to 37,000 die from the disease. The disease is often diagnosed at an advanced stage, and treatment of advanced disease remains challenging. Gemzar has been a standard chemotherapy drug […]

View full entry

Tags: gemzar, gilead, News, Pancreatic Cancer, Recurrent Pancreatic Cancer, simtuzuma, Stage IV Pancreatic Cancer


July 10th, 2014

In Advanced Pancreatic Cancer, Eloxatin® with Folinic Acid and Fluorouracil May Improve Survival

By

In a Phase III study, the addition of the chemotherapy drug Eloxatin® (oxaliplatin) to the chemotherapy regimen of folinic acid and fluorouracil (5-FU) improved outcomes in patients with advanced pancreatic cancer that had progressed on Gemzar® (gemcitabine). These findings were recently published in Journal of Clinical Oncology. Pancreatic cancer is one of the deadliest forms […]

View full entry

Tags: eloxatin, gemzar, News, Pancreatic Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer


July 1st, 2014

Updated Analysis of the MPACT Study in Advanced Pancreatic Cancer Demonstrates Continued Improvement in Survival for Abraxane-based Chemotherapy

By

A follow up report on the results of the Metastatic Pancreatic Adenocarcinoma Clinical Trial (MPACT) study of Abraxane® (nab-paclitaxel) in combination with Gemzar® (gemcitabine) in previously untreated patients with metastatic pancreatic cancer was presented recently at the annual American Society of Clinical Oncology meeting in Chicago.1  Results of the study were initially reported in the New England Journal of Medicine.2 Pancreatic cancer […]

View full entry

Tags: abraxane, gemzar, News, Pancreatic Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer


February 5th, 2014

Dual Vaccines Prolong Survival in Metastatic Pancreatic Cancer

By

The sequential delivery of two vaccines—GVAX and CRS-207—prolonged survival in patients with metastatic pancreatic cancer by about two months, according to the results of a study presented at the 2014 Gastorintestinal Cancers Symposium in San Francisco, California. Pancreatic cancer is one of the deadliest forms of cancer. Each year, approximately 43,000 people are diagnosed with […]

View full entry

Tags: News, Pancreatic Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer


December 25th, 2013

Abraxane Plus Gemzar Improves Survival in Metastatic Pancreatic Cancer

By

Abraxane® (nab-paclitaxel) plus Gemzar® (gemcitabine) improved overall and progression-free survival in patients with previously untreated metastatic pancreatic cancer, according to the results of a study published in the New England Journal of Medicine. Pancreatic cancer is one of the deadliest forms of cancer. Each year, approximately 43,000 people are diagnosed with pancreatic cancer in the […]

View full entry

Tags: News, Pancreatic Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer